Elmiron 100 mg
Elmiron 100 mg is a medicine authorised by Swissmedic under authorisation number 67306. The authorisation holder is Curatis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 September 2020 and the authorisation is valid without a time limit. ATC code G04BX15 places the medicine in the group Urologicals.
| Authorisation number | 67306 |
|---|---|
| Name | Elmiron 100 mg |
| Full name | Elmiron 100 mg, Kapseln |
| Authorisation holder | Curatis AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G04BX15 |
| First authorisation | 24 September 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Elmiron 100 mg, Kapseln | B | 24 September 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 90 | Kapsel(n) | G04BX15 | 05.02.0. | B |
| 2 | 90 | Kapsel(n) | G04BX15 | 05.02.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Elmiron 100 mg authorised in Switzerland?
Yes. Elmiron 100 mg is authorised by Swissmedic under authorisation number 67306, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Elmiron 100 mg have?
Elmiron 100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Elmiron 100 mg?
The authorisation holder is Curatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.